Claims for Patent: 10,989,711
✉ Email this page to a colleague
Summary for Patent: 10,989,711
| Title: | Gold@zinc salen-based metal organic framework composite and methods of use thereof |
| Abstract: | A metal organic framework composite is provided. The composite includes a plurality of zinc ions, each coordinated with a salen ligand to form a salen complex metal-organic framework; and gold nanoparticles dispersed on a surface and pores of the salen complex metal-organic framework. Antibodies may be immobilized on a surface of the gold nanoparticles to be used in highly sensitive diagnostic methods for detecting and quantifying protein biomarkers such as human chorionic gonadotropin hormone. |
| Inventor(s): | Reda Mohamedy Mohamed, Mohammad W. KADI, Said M. El-Sheikh, Sheta M. Sheta |
| Assignee: | King Abdulaziz University |
| Application Number: | US17/104,008 |
| Patent Claims: |
Details for Patent 10,989,711
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | January 15, 1974 | ⤷ Start Trial | 2040-11-25 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | December 27, 1984 | ⤷ Start Trial | 2040-11-25 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 15, 1985 | ⤷ Start Trial | 2040-11-25 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 16, 1990 | ⤷ Start Trial | 2040-11-25 |
| Bel-mar Laboratories, Inc. | CHORIONIC GONADOTROPIN | chorionic gonadotropin | Injection | 017054 | March 26, 1974 | ⤷ Start Trial | 2040-11-25 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
